These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 23718281)

  • 1. Discovery of (R)-(2-fluoro-4-((-4-methoxyphenyl)ethynyl)phenyl) (3-hydroxypiperidin-1-yl)methanone (ML337), an mGlu3 selective and CNS penetrant negative allosteric modulator (NAM).
    Wenthur CJ; Morrison R; Felts AS; Smith KA; Engers JL; Byers FW; Daniels JS; Emmitte KA; Conn PJ; Lindsley CW
    J Med Chem; 2013 Jun; 56(12):5208-12. PubMed ID: 23718281
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of Novel Central Nervous System Penetrant Metabotropic Glutamate Receptor Subtype 2 (mGlu
    Childress ES; Wieting JM; Felts AS; Breiner MM; Long MF; Luscombe VB; Rodriguez AL; Cho HP; Blobaum AL; Niswender CM; Emmitte KA; Conn PJ; Lindsley CW
    J Med Chem; 2019 Jan; 62(1):378-384. PubMed ID: 30350962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and SAR of substituted pyrazolo[1,5-a]quinazolines as dual mGlu(2)/mGlu(3) NAMs.
    Wenthur CJ; Morrison RD; Daniels JS; Conn PJ; Lindsley CW
    Bioorg Med Chem Lett; 2014 Jun; 24(12):2693-8. PubMed ID: 24794112
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of a novel, CNS-penetrant, metabotropic glutamate receptor 3 (mGlu3) NAM probe (ML289) derived from a closely related mGlu5 PAM.
    Sheffler DJ; Wenthur CJ; Bruner JA; Carrington SJ; Vinson PN; Gogi KK; Blobaum AL; Morrison RD; Vamos M; Cosford ND; Stauffer SR; Daniels JS; Niswender CM; Conn PJ; Lindsley CW
    Bioorg Med Chem Lett; 2012 Jun; 22(12):3921-5. PubMed ID: 22607673
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of the first M5-selective and CNS penetrant negative allosteric modulator (NAM) of a muscarinic acetylcholine receptor: (S)-9b-(4-chlorophenyl)-1-(3,4-difluorobenzoyl)-2,3-dihydro-1H-imidazo[2,1-a]isoindol-5(9bH)-one (ML375).
    Gentry PR; Kokubo M; Bridges TM; Kett NR; Harp JM; Cho HP; Smith E; Chase P; Hodder PS; Niswender CM; Daniels JS; Conn PJ; Wood MR; Lindsley CW
    J Med Chem; 2013 Nov; 56(22):9351-5. PubMed ID: 24164599
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery of novel allosteric modulators of metabotropic glutamate receptor subtype 5 reveals chemical and functional diversity and in vivo activity in rat behavioral models of anxiolytic and antipsychotic activity.
    Rodriguez AL; Grier MD; Jones CK; Herman EJ; Kane AS; Smith RL; Williams R; Zhou Y; Marlo JE; Days EL; Blatt TN; Jadhav S; Menon UN; Vinson PN; Rook JM; Stauffer SR; Niswender CM; Lindsley CW; Weaver CD; Conn PJ
    Mol Pharmacol; 2010 Dec; 78(6):1105-23. PubMed ID: 20923853
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design and Synthesis of
    Engers JL; Bollinger KA; Weiner RL; Rodriguez AL; Long MF; Breiner MM; Chang S; Bollinger SR; Bubser M; Jones CK; Morrison RD; Bridges TM; Blobaum AL; Niswender CM; Conn PJ; Emmitte KA; Lindsley CW
    ACS Med Chem Lett; 2017 Sep; 8(9):925-930. PubMed ID: 28947938
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ADX47273 [S-(4-fluoro-phenyl)-{3-[3-(4-fluoro-phenyl)-[1,2,4]-oxadiazol-5-yl]-piperidin-1-yl}-methanone]: a novel metabotropic glutamate receptor 5-selective positive allosteric modulator with preclinical antipsychotic-like and procognitive activities.
    Liu F; Grauer S; Kelley C; Navarra R; Graf R; Zhang G; Atkinson PJ; Popiolek M; Wantuch C; Khawaja X; Smith D; Olsen M; Kouranova E; Lai M; Pruthi F; Pulicicchio C; Day M; Gilbert A; Pausch MH; Brandon NJ; Beyer CE; Comery TA; Logue S; Rosenzweig-Lipson S; Marquis KL
    J Pharmacol Exp Ther; 2008 Dec; 327(3):827-39. PubMed ID: 18753411
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surveying heterocycles as amide bioisosteres within a series of mGlu
    Reed CW; Washecheck JP; Quitlag MC; Jenkins MT; Rodriguez AL; Engers DW; Blobaum AL; Conn PJ; Niswender CM; Lindsley CW
    Bioorg Med Chem Lett; 2019 May; 29(10):1211-1214. PubMed ID: 30910459
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of an Orally Bioavailable and Central Nervous System (CNS) Penetrant mGlu
    Reed CW; Yohn SE; Washecheck JP; Roenfanz HF; Quitalig MC; Luscombe VB; Jenkins MT; Rodriguez AL; Engers DW; Blobaum AL; Conn PJ; Niswender CM; Lindsley CW
    J Med Chem; 2019 Feb; 62(3):1690-1695. PubMed ID: 30608678
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and Preliminary Studies of a Novel Negative Allosteric Modulator, 7-((2,5-Dioxopyrrolidin-1-yl)methyl)-4-(2-fluoro-4-[
    Zhang X; Kumata K; Yamasaki T; Cheng R; Hatori A; Ma L; Zhang Y; Xie L; Wang L; Kang HJ; Sheffler DJ; Cosford NDP; Zhang MR; Liang SH
    ACS Chem Neurosci; 2017 Sep; 8(9):1937-1948. PubMed ID: 28565908
    [TBL] [Abstract][Full Text] [Related]  

  • 12. mGlu
    Tyler RE; Van Voorhies K; Blough BE; Landavazo A; Besheer J
    Pharmacol Biochem Behav; 2024 Jun; 239():173767. PubMed ID: 38608960
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery of a Selective and CNS Penetrant Negative Allosteric Modulator of Metabotropic Glutamate Receptor Subtype 3 with Antidepressant and Anxiolytic Activity in Rodents.
    Engers JL; Rodriguez AL; Konkol LC; Morrison RD; Thompson AD; Byers FW; Blobaum AL; Chang S; Venable DF; Loch MT; Niswender CM; Daniels JS; Jones CK; Conn PJ; Lindsley CW; Emmitte KA
    J Med Chem; 2015 Sep; 58(18):7485-500. PubMed ID: 26335039
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of a highly potent, novel M5 positive allosteric modulator (PAM) demonstrating CNS exposure: 1-((1H-indazol-5-yl)sulfoneyl)-N-ethyl-N-(2-(trifluoromethyl)benzyl)piperidine-4-carboxamide (ML380).
    Gentry PR; Kokubo M; Bridges TM; Noetzel MJ; Cho HP; Lamsal A; Smith E; Chase P; Hodder PS; Niswender CM; Daniels JS; Conn PJ; Lindsley CW; Wood MR
    J Med Chem; 2014 Sep; 57(18):7804-10. PubMed ID: 25147929
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design and Synthesis of mGlu
    Bollinger KA; Felts AS; Brassard CJ; Engers JL; Rodriguez AL; Weiner RL; Cho HP; Chang S; Bubser M; Jones CK; Blobaum AL; Niswender CM; Conn PJ; Emmitte KA; Lindsley CW
    ACS Med Chem Lett; 2017 Sep; 8(9):919-924. PubMed ID: 28947937
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Negative allosteric modulators of group II metabotropic glutamate receptors: A patent review (2015 - present).
    Qunies AM; Emmitte KA
    Expert Opin Ther Pat; 2021 Aug; 31(8):687-708. PubMed ID: 33719801
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Positive allosteric modulators (PAMs) of the group II metabotropic glutamate receptors: Design, synthesis, and evaluation as ex-vivo tool compounds.
    Yamada Y; Gilliland K; Xiang Z; Haymer D; Crocker KE; Loch MT; Schulte ML; Rodriguez AL; Niswender CM; Jeffrey Conn P; Lindsley CW; Melancon BJ
    Bioorg Med Chem Lett; 2021 Oct; 50():128342. PubMed ID: 34461178
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 1,3,5-Trisubstituted Pyrazoles as Potent Negative Allosteric Modulators of the mGlu
    Van Gool M; Alonso De Diego SA; Delgado O; Trabanco AA; Jourdan F; Macdonald GJ; Somers M; Ver Donck L
    ChemMedChem; 2017 Jun; 12(12):905-912. PubMed ID: 28263042
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.